Displaying drugs 14951 - 14975 of 15187 in total
MBT-0312
MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors.
Investigational
ICA-105665
ICA-105665 is a novel small molecule compound for the treatment of epilepsy. It is a novel opener of the KCNQ ion channel which in preclinical studies has demonstrated a broad spectrum of activity in models of epilepsy. In addition, ICA-105665 has also demonstrated activity in certain models of neuropathic pain.
Investigational
EVT 201
EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational
Flaviolin
Experimental
DPI59
Experimental
4-Hydroxy-3-Methyl Butyl Diphosphate
Experimental
Nitrosoethane
Experimental
Methionine Phosphinate
Experimental
Tioxolone
Experimental
T-5224
T-5224 is an investigational drug developed to treat Sepsis-induced Acute Kidney Injury. It's mechanism of action is to inhibit c-Fos/activator protein-1.
Investigational
8-azaxanthine
Experimental
3,5-Diaminophthalhydrazide
Experimental
TAK-475
TAK-475 is a "squalene synthase inhibitor", a type of cholesterol-lowering drug that has not yet been brought to market.
Investigational
Napabucasin
Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational
MBO7133
MB07133 is a HepDirect prodrug of an activated form of cytarabine (araC), an anti-cancer drug that is used to treat leukemia but is ineffective against primary liver cancer. AraC's anti-cancer activity is associated with its ability to be converted to its biologically active form, araCTP. However, araC is only slowly...
Investigational
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Methyl isocyanate
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
SLx-4090
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
Investigational
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Oxomemazine
Experimental
9-Deazahypoxanthine
Experimental
Isatoic anhydride
Experimental
Displaying drugs 14951 - 14975 of 15187 in total